Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.
Mylan has launched generic versions of two drugs to treat bipolar disorder and allergies, the company said Tuesday.
The Food and Drug Administration has approved a generic drug for anxiety made by Hi-Tech Pharmacal, the drug maker said Tuesday.
Mylan must pay $77 million to four health insurers over allegations that it sought to control the market on ingredients used for two anti-anxiety medicines, according to published reports.
Metabolex has entered an agreement to discover and develop Type 2 diabetes drugs with a...
The Food and Drug Administration has approved a generic drug for anxiety disorder made by...